首页|结直肠癌生物标志物在诊断和预后中的应用:现状与未来展望

结直肠癌生物标志物在诊断和预后中的应用:现状与未来展望

扫码查看
结直肠癌(colorectal cancer,CRC)是全球范围内常见的恶性肿瘤之一,其早期诊断和预后评估对提高患者生存率和生活质量至关重要.生物标志物作为一种非侵入性且高敏感性的检测手段,近年来在CRC的研究中受到广泛关注.本研究综述了当前CRC生物标志物的研究进展,探讨其在诊断和预后中的应用,并展望其未来的研究方向.
Application of biomarkers in diagnosis and prognosis of colorectal cancer:a review of recent studies
Colorectal cancer(CRC)is one of the most common malignancies in the world.The early diagnosis and prognosis assessment are essential to improve the survival rate and quality of patient.In recent years,as a non-invasive and highly sensitive means of detection,biomarkers have received extensive attention in the research of CRC.In this paper,we reviewed the current research progress of CRC biomarkers,discussed their application in diagnosis and prognosis,and looked forward to the future research.

Colorectal cancerBiomarkersDiagnosisPrognosis

张书婧、周庆红、姜伟、刘英华、张静、钱智勇

展开 >

天津市疾病预防控制中心卫生检验检测所,天津 300011

国家卫生健康委员会食品安全风险评估与标准研制特色实验室

天津市第一中心医院胃肠外科

结直肠癌 生物标志物 诊断 预后

2024

环境与健康杂志
中华预防医学会,天津市疾病预防控制中心

环境与健康杂志

CSTPCD
影响因子:0.658
ISSN:1001-5914
年,卷(期):2024.41(11)